Author

Ibuki Harada

Icahn School of Medicine at Mount SinaiORCID 0009-0006-8154-350XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Criseyda MartineziD· 1 shared Eunjee LeeiD· 1 shared Hanna Yoko IrieiD· 1 shared Jun ZhuiD· 1 shared Koichi ItoiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

5 top collaborators · 10 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Criseyda MartinezORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintJan 11, 2025

Inhibition of EMT driver PTK6 enhances anti-tumor immune responses against triple-negative breast cancer

Ibuki Harada, Criseyda Martinez, Koichi Ito…·Hanna Yoko Irie

This study shows that inhibiting PTK6 in triple-negative breast cancer enhances anti-tumor immune responses by increasing CD8+ T and NK cells and reducing immunosuppressive cells.

DOI 10.1101/2025.01.11.632044

mousebulk RNA-seq

𝕏 PostBluesky